StockNews.AI
XTNT
StockNews.AI
172 days

Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

1. XTNT will release Q4 and full-year 2024 financial results on March 6, 2025. 2. A conference call with executives will provide insights after market close.

Earnings
+7.26%Current Return
VS
+1.56%S&P 500
$0.475402/28 08:05 AM EDTEvent Start
$0.509903/03 08:19 AM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Earnings releases often affect stock prices significantly, especially if results exceed expectations. Historical examples show tech companies often rally post-earnings.

How important is it?

The upcoming earnings release is pivotal for investors, impacting XTNT's valuation and prospects.

Why Short Term?

Expect immediate market reaction post-results release, influencing stock movement for the next week.

Related Companies

SPNESTXSNUVA
BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2024, after the close of the financial markets on Thursday, March 6, 2025. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, March 6, 2025 at 4:30 PM ET to review results.

Related News